rs13135778

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152618.3(BBS12):​c.1399G>A​(p.Asp467Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 1,613,942 control chromosomes in the GnomAD database, including 37,042 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. D467D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.16 ( 2432 hom., cov: 33)
Exomes 𝑓: 0.21 ( 34610 hom. )

Consequence

BBS12
NM_152618.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.624

Publications

26 publications found
Variant links:
Genes affected
BBS12 (HGNC:26648): (Bardet-Biedl syndrome 12) The protein encoded by this gene is part of a complex that is involved in membrane trafficking. The encoded protein is a molecular chaperone that aids in protein folding upon ATP hydrolysis. This protein also plays a role in adipocyte differentiation. Defects in this gene are a cause of Bardet-Biedl syndrome type 12. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, May 2010]
BBS12 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, Myriad Women’s Health
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021182895).
BP6
Variant 4-122743291-G-A is Benign according to our data. Variant chr4-122743291-G-A is described in ClinVar as Benign. ClinVar VariationId is 166727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.227 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS12NM_152618.3 linkc.1399G>A p.Asp467Asn missense_variant Exon 2 of 2 ENST00000314218.8 NP_689831.2 Q6ZW61
BBS12NM_001178007.2 linkc.1399G>A p.Asp467Asn missense_variant Exon 3 of 3 NP_001171478.1 Q6ZW61
BBS12XM_011531680.3 linkc.1399G>A p.Asp467Asn missense_variant Exon 2 of 2 XP_011529982.1 Q6ZW61

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS12ENST00000314218.8 linkc.1399G>A p.Asp467Asn missense_variant Exon 2 of 2 1 NM_152618.3 ENSP00000319062.3 Q6ZW61
BBS12ENST00000542236.5 linkc.1399G>A p.Asp467Asn missense_variant Exon 3 of 3 2 ENSP00000438273.1 Q6ZW61

Frequencies

GnomAD3 genomes
AF:
0.157
AC:
23917
AN:
152102
Hom.:
2432
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0626
Gnomad AMI
AF:
0.167
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.166
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.126
Gnomad FIN
AF:
0.195
Gnomad MID
AF:
0.155
Gnomad NFE
AF:
0.230
Gnomad OTH
AF:
0.153
GnomAD2 exomes
AF:
0.165
AC:
41447
AN:
251378
AF XY:
0.170
show subpopulations
Gnomad AFR exome
AF:
0.0609
Gnomad AMR exome
AF:
0.0826
Gnomad ASJ exome
AF:
0.166
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.200
Gnomad NFE exome
AF:
0.231
Gnomad OTH exome
AF:
0.181
GnomAD4 exome
AF:
0.209
AC:
305671
AN:
1461722
Hom.:
34610
Cov.:
35
AF XY:
0.208
AC XY:
151534
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.0603
AC:
2019
AN:
33478
American (AMR)
AF:
0.0868
AC:
3882
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
4336
AN:
26132
East Asian (EAS)
AF:
0.000453
AC:
18
AN:
39700
South Asian (SAS)
AF:
0.137
AC:
11822
AN:
86254
European-Finnish (FIN)
AF:
0.205
AC:
10945
AN:
53408
Middle Eastern (MID)
AF:
0.160
AC:
923
AN:
5768
European-Non Finnish (NFE)
AF:
0.234
AC:
260665
AN:
1111864
Other (OTH)
AF:
0.183
AC:
11061
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
13545
27090
40636
54181
67726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8624
17248
25872
34496
43120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.157
AC:
23917
AN:
152220
Hom.:
2432
Cov.:
33
AF XY:
0.153
AC XY:
11362
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0625
AC:
2596
AN:
41548
American (AMR)
AF:
0.123
AC:
1888
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
575
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5186
South Asian (SAS)
AF:
0.126
AC:
609
AN:
4826
European-Finnish (FIN)
AF:
0.195
AC:
2064
AN:
10584
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.230
AC:
15663
AN:
67990
Other (OTH)
AF:
0.150
AC:
317
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1021
2043
3064
4086
5107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.200
Hom.:
9542
Bravo
AF:
0.146
TwinsUK
AF:
0.231
AC:
856
ALSPAC
AF:
0.230
AC:
888
ESP6500AA
AF:
0.0690
AC:
304
ESP6500EA
AF:
0.226
AC:
1941
ExAC
AF:
0.170
AC:
20587
Asia WGS
AF:
0.0640
AC:
224
AN:
3478
EpiCase
AF:
0.222
EpiControl
AF:
0.220

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 21, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 12 Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 1 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Bardet-Biedl syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
2.8
DANN
Benign
0.24
DEOGEN2
Benign
0.087
T;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.13
T;.
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-2.1
N;N
PhyloP100
0.62
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.95
N;N
REVEL
Benign
0.15
Sift
Benign
1.0
T;T
Sift4G
Benign
0.96
T;T
Polyphen
0.0
B;B
Vest4
0.018
MPC
0.081
ClinPred
0.00029
T
GERP RS
1.9
Varity_R
0.031
gMVP
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13135778; hg19: chr4-123664446; COSMIC: COSV58561963; COSMIC: COSV58561963; API